BEI
AMED

Benjamin Edwards Inc’s Amedisys AMED Stock Holding History

Benjamin Edwards Inc’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-918
Closed -$84K – 634
2023
Q2 		$84K Sell
918
-88
-9% -$7.22K 0.02% 411
2023
Q1 		$74K Buy
1,006
+127
+14% +$11K 0.02% 407
2022
Q4 		$73K Buy
879
+140
+19% +$12.6K 0.02% 384
2022
Q3 		$72K Buy
739
+16
+2% +$1.91K 0.02% 381
2022
Q2 		$76K Buy
723
+174
+32% +$22.2K 0.02% 377
2022
Q1 		$95K Buy
549
+543
+9,050% +$81.1K 0.03% 365
2021
Q4 		$1K Buy
+6
New +$964 ﹤0.01% 688

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Benjamin Edwards Inc's AMED Position: Q3 2023 in Review

Benjamin Edwards Inc sold out of Amedisys (AMED) in Q3 2023, closing a stake of 918 shares — an estimated $84K sold.

Benjamin Edwards Inc first reported a position in AMED in Q4 2021 and held it in 7 quarters. The position peaked at $95K in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Benjamin Edwards Inc reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Benjamin Edwards Inc sold 918 Amedisys shares in Q3 2023, an estimated $84K.
  • Benjamin Edwards Inc first reported a position in Amedisys in Q4 2021 and held it in 7 quarters.
  • Benjamin Edwards Inc's Amedisys position peaked at $95K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Benjamin Edwards Inc's 13F filing for Q3 2023, filed 13 Nov 2023.